NCT02051413View on ClinicalTrials.gov

Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)

PHASE4CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

February 18, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

May 31, 2018

Conditions
Major Depressive DisorderMajor Depressive Episode
Interventions
DRUG

Venlafaxine extended release

antidepressant drug

Trial Locations (1)

94275

CHU de Bicetre, Le Kremlin-Bicêtre

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT02051413 - Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN) | Biotech Hunter | Biotech Hunter